Edition:
United Kingdom

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

38.36EUR
23 Jan 2018
Change (% chg)

€-0.06 (-0.16%)
Prev Close
€38.42
Open
€38.36
Day's High
€38.48
Day's Low
€38.08
Volume
225,075
Avg. Vol
341,921
52-wk High
€40.80
52-wk Low
€26.10

Latest Key Developments (Source: Significant Developments)

Recordati Q3 net profit up at EUR ‍​72.8 mln, confirms FY targets
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - RECORDATI ::Q3 NET PROFIT EUR ‍​72.8 MILLION VERSUS EUR 59.6 MILLION YEAR AGO.Q3 REVENUE EUR 313.0 ‍​MILLION VERSUS EUR 274.5 MILLION YEAR AGO.INTERIM 2017 DIVIDEND OF EUR 0.42 PER SHARE TO BE DISTRIBUTED‍​.CONFIRMS FY 2017 TARGETS.  Full Article

Recordati: European Commission approves Reagila as schizophrenia treatment
Wednesday, 19 Jul 2017 

July 19 (Reuters) - RECORDATI SPA ::EUROPEAN COMMISSION APPROVES REAGILA (CARIPRAZINE) FOR TREATMENT OF SCHIZOPHRENIA.  Full Article

Recordati signs license agreement with Richter to commercialize cariprazine
Tuesday, 2 Aug 2016 

Recordati Industria Chimica e Farmaceutica SpA : Signs a license agreement with Gedeon Richter (Richter) to commercialize cariprazine in Western Europe and in Algeria, in Tunisia and in Turkey . The European Medicines Agency (EMA) started the evaluation of Richter's marketing authorization application for cariprazine, an atypical antipsychotic, for the treatment of schizophrenia in March . Recordati to make an upfront payment and further milestone payments depending on the progress of both the regulatory procedure and the product commercialization . Further sales-related royalties will become payable to Richter following the launch of the product .Richter to be responsible for conducting pediatric clinical studies according to the Pediatric Investigation Plan, as required by the European Medicines Agency's PDCO (Pediatric Committee) and it shall be co-financed with Recordati.  Full Article

Recordati H1 net profit jumps at EUR 122.7 mln
Thursday, 28 Jul 2016 

Recordati Industria Chimica E Farmaceutica SpA : H1 net profit 122.7 million euros ($136.07 million) versus 103.2 million euros a year ago, up 18.9 percent .H1 net revenues 587.9 million euros versus 539.1 million euros a year ago, up 9.1 percent.  Full Article

Recordati buys 100 pct stake in Swiss pharmaceutical company Pro Farma
Thursday, 14 Jul 2016 

Recordati Industria Chimica e Farmaceutica SpA : Announces acquisition of 100 percent of share capital of Pro Farma AG, a swiss pharmaceutical company .Value of transaction (enterprise value) is of 16 million Swiss francs ($16.31 million) and will be funded from existing liquidity.  Full Article

Italy's Recordati buys Italchimici in deal valued at 130 mln euros
Tuesday, 31 May 2016 

Italy's Recordati Industria Chimica E Farmaceutica says: has bought all of Italian pharmaceutical company Italchimici . deal valued at about 130 million euros .to be funded in cash.  Full Article

Recordati Industria Chimica E Farmaceutica SpA proposes dividend on 2015 of 0.60 euros per share
Tuesday, 8 Mar 2016 

Recordati Industria Chimica E Farmaceutica SpA:Proposes dividend on 2015 of 0.60 euro per share, of which 0.30 euro already paid.  Full Article